What Vitamins Remove Plaque From Arteries?

No vitamin has been proven to remove existing plaque from your arteries. That is the honest starting point, and it matters because the question implies a fix that the science has not delivered. What research does show is more nuanced and still genuinely useful: certain vitamins can slow plaque growth, reduce arterial stiffening, and in some cases change the composition of plaque in ways that make it less dangerous. The gap between “remove” and “slow down” is significant, and understanding which vitamins actually have evidence behind them can save you from wasting money on supplements that do nothing or, worse, cause harm.

Vitamin K2 Has the Strongest Case for Slowing Calcification

If any vitamin comes close to a plaque-related benefit, vitamin K2 is the frontrunner. The reason centers on a protein called Matrix Gla Protein, or MGP, which is the most powerful natural inhibitor of calcification in the human body. MGP needs vitamin K to become biologically active. Without enough vitamin K, MGP stays in its inactive form and cannot do its job of preventing calcium from accumulating in artery walls.¹ Animal studies illustrate how critical this protein is: mice that completely lack MGP die within two months from widespread arterial calcification so severe it causes arterial rupture.²

The clinical trial data is encouraging but falls short of dramatic reversal. The DANCODE trial, one of the most rigorous studies on this question, gave patients with severe coronary artery calcification a combination of vitamin K2 and vitamin D3 or a placebo. Both groups saw their calcium scores increase over time, because that is what calcified plaque does. But the supplement group’s scores increased less: by about 196 units compared to 248 units in the placebo group. The progression of calcified plaque volume was also lower in the treatment group.³ A similar randomized trial in older men found comparable results, with statistically significant slowing of calcification among participants who started with the heaviest calcium burden.⁴

A separate study using vitamin K1 (phylloquinone, the form found in leafy greens rather than fermented foods) found no overall difference between supplement and control groups in calcium score progression. But among the participants who actually took their supplements consistently, those with preexisting calcification saw about 6% less progression than the control group.⁵ The pattern across these trials is consistent: vitamin K does not erase calcium deposits, but it can slow the rate at which they grow, particularly in people who already have significant buildup.

Vitamin D’s Complicated Relationship With Your Arteries

Vitamin D often appears alongside K2 in supplement marketing for arterial health, and there is a reason for the pairing, but the story is more complicated than ads suggest. Low vitamin D levels are linked to stiffer arteries. In healthy adults, researchers found that lower vitamin D was independently associated with higher arterial stiffness and worse vascular function, even after accounting for cholesterol, inflammation, and other risk factors.⁶

Supplementation can help if you are deficient. A placebo-controlled trial in overweight adults with vitamin D deficiency found a dose-dependent improvement in arterial stiffness. Those taking the highest dose saw meaningful reductions in pulse wave velocity, a standard measure of how stiff arteries are, while the placebo group got slightly worse.⁷ But arterial stiffness is not the same thing as plaque. Stiff arteries are a risk factor for cardiovascular events, and improving stiffness is good, but it does not mean plaque is shrinking.

Here is where vitamin D gets tricky: too much can actually promote the very calcification you are trying to prevent. When vitamin D metabolism gets out of balance, particularly with excess calcium intake, it can drive calcium and phosphate into blood vessel walls and contribute to endothelial dysfunction.⁸ This is one reason the K2-plus-D3 pairing exists in supplement formulations: K2 helps direct calcium toward bones and away from arteries, at least in theory. The DANCODE trial used both together, and the results were positive for slowing calcification, but the studies do not cleanly separate what each vitamin contributed on its own.

Niacin Changed the Conversation, Then Fell Out of Favor

Niacin, also known as vitamin B3, was once considered a standout for plaque management. At high therapeutic doses (around 2 grams daily, far beyond what you get from food), niacin raises HDL cholesterol more powerfully than any other available therapy and significantly reduces another problematic blood fat called lipoprotein(a).⁹ Imaging studies confirmed that these lipid changes translated into physical changes in arteries. An MRI study showed that high-dose niacin added to statin therapy reduced the thickness of carotid artery walls over 12 months. The ARBITER 6 trial compared niacin to ezetimibe (another cholesterol drug) in statin-treated patients and found niacin significantly reduced carotid plaque thickness at both 8 and 14 months.¹⁰

The enthusiasm cooled after larger outcome trials failed to show that adding niacin to statin therapy actually reduced heart attacks or strokes. The AIM-HIGH and HPS2-THRIVE trials both disappointed, and niacin’s role has been downgraded considerably. It remains an interesting compound for plaque biology, but cardiologists no longer recommend it routinely. And the doses required for any arterial effect are pharmaceutical-grade, not something you achieve with a B-complex supplement from the drugstore. At those doses, side effects like severe flushing, liver stress, and blood sugar disruption are common.

Vitamin C Protects Artery Walls but Does Not Reverse Disease

Vitamin C gets a lot of attention in alternative health circles as a plaque fighter, partly because of its well-established role in collagen synthesis and connective tissue repair. Lab studies show that vitamin C inhibits calcification in cultured human aortic smooth muscle cells, reducing the amount of calcium that accumulates in the tissue those cells produce.¹¹ It also supports the inner lining of blood vessels by boosting nitric oxide availability, which helps regulate blood flow, and by protecting endothelial cells from oxidative damage.¹²

The same review that described these protective effects, though, was careful to note that vitamin C may play a role in preventing the early endothelial dysfunction that starts the atherosclerosis process but probably cannot reverse established inflammatory vascular disease.¹² This distinction between prevention and reversal matters enormously. If you already have significant plaque, vitamin C is not going to dissolve it. A major clinical trial, the St. Francis Heart Study, tested vitamin C (1 gram daily) plus vitamin E (1,000 units daily) alongside low-dose atorvastatin in over 1,000 adults with high coronary calcium scores. The treatment had no effect on calcification progression.¹³

That result was striking because it combined the two most popular antioxidant vitamins with a proven cholesterol-lowering drug, and the calcification still progressed at the same rate. It suggests that once calcium has deposited in coronary arteries, antioxidant vitamins are not enough to stop its advance.

Vitamin E and the Antioxidant Hypothesis That Did Not Pan Out

The logic behind vitamin E supplementation for heart health seemed solid for years: oxidation of LDL cholesterol is a key step in plaque formation, vitamin E is a fat-soluble antioxidant that can intercept that oxidation, so supplementing should help. Researchers confirmed that vitamin E does get oxidized inside human atherosclerotic lesions, which means it is indeed encountering the oxidative environment where plaque develops.¹⁴ One controlled trial found that people taking high-dose supplemental vitamin E had slower progression of carotid artery thickening compared to low vitamin E users, but only in the group not taking cholesterol medication. Among those already on treatment, vitamin E made no additional difference.¹⁵

Large outcome trials have since failed to show that vitamin E supplementation reduces heart attacks, strokes, or cardiovascular death. Some even raised concerns about increased bleeding risk and, at very high doses, slightly higher mortality. The antioxidant hypothesis for atherosclerosis has not held up in clinical practice, even though the basic biochemistry is real. This is one of those cases where what happens in a test tube and what happens inside a living person turn out to be different things.

B Vitamins Help Only if You Have Elevated Homocysteine

Folate, B6, and B12 are the trio of B vitamins that lower homocysteine, an amino acid linked to increased cardiovascular risk. The idea was that bringing homocysteine down would slow atherosclerosis. A randomized trial tested high-dose B vitamin supplementation and found that overall, carotid artery thickness progressed at similar rates in the supplement and placebo groups. But in participants who started with elevated homocysteine (above roughly 9 micromol/L), B vitamin supplementation significantly slowed the thickening of carotid artery walls compared to placebo. In those with normal homocysteine levels, there was no benefit. And B vitamins had no effect on calcification in the aorta or coronary arteries regardless of homocysteine levels.¹⁶

This is a useful finding because it highlights a theme that runs through all of this research: vitamins tend to help when there is a deficiency or a specific metabolic problem to correct. If your homocysteine is already normal, throwing B vitamins at your arteries will not accomplish anything. The benefit is corrective, not additive. A follow-up analysis from the same group confirmed that the carotid wall benefit was specific to the elevated-homocysteine subgroup and to individuals at lower overall cardiovascular risk.¹⁷

What About Combining Vitamins?

The ASAP study tested six years of combined vitamin C and vitamin E supplementation in people at moderate cardiovascular risk. The combination slowed the progression of carotid artery wall thickening by about a quarter overall, with a stronger effect in men (roughly a third slower) than in women, where the reduction was not statistically significant.¹⁸ That sounds promising, but remember the St. Francis Heart Study: when similar antioxidant doses were tested against coronary calcification rather than carotid wall thickness, there was zero effect.¹³

The discrepancy is not necessarily contradictory. Carotid wall thickening and coronary calcification are related but distinct measures. The carotid artery is more muscular and superficial, while coronary calcification reflects calcium deposition deep in the heart’s own blood supply. Vitamins might influence one process without affecting the other. But for someone wondering whether a vitamin cocktail can clear their arteries, the honest answer is that even the most optimistic data shows only modest slowing of one type of plaque measure and no effect on another.

When Supplements Backfire

Calcium supplements deserve special attention here because many people take them alongside vitamins D and K for bone health, and the interaction with arterial calcification is not benign. A 10-year follow-up of a large multi-ethnic cohort found that calcium supplement use was associated with a 22% increased risk of developing new coronary artery calcification, even after accounting for total calcium intake from food.¹⁹ Dietary calcium from food did not carry the same risk. The likely explanation is that supplements deliver a large bolus of calcium at once, which can briefly spike blood calcium levels in ways that food does not.

There is also an underappreciated interaction between statins and vitamin K. Statins, which are by far the most effective proven therapy for plaque management, can interfere with vitamin K conversion in the body, potentially impairing the function of vitamin K-dependent proteins like MGP.²⁰ This raises the question of whether people on statins might specifically benefit from vitamin K2 supplementation to compensate, a question the DANCODE trial was partly designed to explore. The answer seems to be cautiously yes for slowing calcification, but no large outcomes trial has yet confirmed that adding K2 to a statin actually prevents heart attacks.

Food Patterns Matter More Than Individual Vitamins

A randomized trial of the Mediterranean diet in high-risk cardiovascular patients found that both versions of the diet (one enriched with extra virgin olive oil, the other with nuts) dramatically reduced inflammatory markers tied to plaque instability. C-reactive protein dropped by roughly 45% and 35%, and interleukin-6, another inflammation marker, dropped by about 95% and 90% in the two diet groups compared to a low-fat control diet.²¹ Those are far larger effect sizes than any vitamin supplement has achieved in isolation.

This is not a coincidence. Whole dietary patterns deliver vitamins K, C, D, E, and B in their natural matrix alongside fiber, polyphenols, and healthy fats. The synergies are difficult to replicate in pill form. Fermented foods and leafy greens provide K2 and K1. Citrus and vegetables provide vitamin C. Fatty fish provides both vitamin D and omega-3 fatty acids. Nuts and seeds provide vitamin E. When you eat these foods together, the nutrients arrive in smaller, sustained doses that the body handles differently than supplement boluses.

How Plaque Gets Measured and Why It Matters for Interpreting Vitamin Studies

Part of the confusion about whether vitamins help with plaque comes from the fact that “plaque” is not one thing, and different imaging tools measure different aspects of it. Coronary artery calcium scoring uses CT scans to quantify how much calcium has deposited in heart arteries. This is the measure used in the K2 trials and the St. Francis Heart Study. Carotid intima-media thickness, or IMT, uses ultrasound to measure how thick the inner layers of the carotid artery wall have become, and that is what the niacin, B vitamin, and ASAP antioxidant studies measured. Coronary CT angiography can assess overall plaque volume and distinguish between calcified (hard) and noncalcified (soft) plaque. MRI can differentiate major plaque components and accurately measure arterial wall dimensions, which has made it useful as an endpoint in therapeutic studies.²²²³

These distinctions matter because a treatment that slows carotid wall thickening might not budge coronary calcium scores, and a therapy that reduces noncalcified plaque volume might paradoxically increase the calcium score as soft plaque converts to more stable calcified plaque. The major clinical trials that have demonstrated actual plaque regression, where the total volume of plaque in an artery shrinks, have relied on aggressive LDL-lowering with statins or newer drugs like PCSK9 inhibitors, not on vitamins.²⁴ Reducing LDL cholesterol to very low levels can safely shrink overall plaque burden and change its composition to be less rupture-prone. No vitamin has demonstrated this level of plaque regression in humans.

The Sex Difference That Rarely Gets Mentioned

Several of the vitamin trials show a pattern that rarely makes it into supplement marketing: the effects often differ between men and women. In the ASAP antioxidant study, the combined C and E supplementation slowed carotid wall thickening by about a third in men but had no statistically significant effect in women.¹⁸ The main DANCODE trial reported that treatment effects were consistent across sexes, but the earlier K2 trial in the pipeline enrolled only men.⁴ Women develop atherosclerosis differently, with more diffuse plaque patterns and more microvascular disease, and hormone status affects vascular calcification pathways. Before assuming that a vitamin strategy tested predominantly in older men applies equally to everyone, it is worth noting how thin the evidence is for women specifically.

Older adults also face a unique challenge: the people most likely to have significant plaque are the same ones most likely to be on statins, blood thinners, and other medications. Vitamin K supplementation can interfere with warfarin (a blood thinner that works by blocking vitamin K). Niacin at therapeutic doses can worsen blood sugar control in people with diabetes. Vitamin E at high doses can increase bleeding risk, which compounds the effects of aspirin or anticoagulants. The context of what else you are taking changes whether a given vitamin is helpful, useless, or genuinely dangerous.